文献速递流行病学与生物统计医学教育与科研方法

COVID-19 L·OVE证据库高度全面,可作为COVID-19研究的单一来源

COVID-19 Living Overview of Evidence repository is highly comprehensive and can be used as a single source for COVID-19 studies.
PubMed 文献 · J Clin Epidemiol · 2022-05-19

本研究以2021年4月发表的COVID-19系统综述所纳入的全部研究为样本,评估COVID-19 L·OVE证据库的全面性与时效性。结果显示,该库对2,132项研究的全面性为99.67%(2,125/2,132),时效性为96.48%(2,057/2,132),随机试验的全面性与时效性均为100%(82/82)。

要点

  • COVID-19 L·OVE证据库对系统综述纳入研究的全面性达99.67%(2,125/2,132)。
  • 该库时效性为96.48%(2,057/2,132),随机试验的全面性与时效性均为100%(82/82)。
  • 使用该库替代传统多数据库手工检索可节省系统综述工作量并提高证据合成的全面性与及时性。

核心结论

  • COVID-19 L·OVE证据库高度全面且时效性强,使用该库替代传统多数据库手工检索可为系统综述作者节省大量工作,并提高证据合成的全面性与及时性,对支持动态证据合成过程尤为重要。

研究设计与样本

  • 样本取自2021年4月发表的COVID-19系统综述所纳入的全部研究,通过计算样本中纳入COVID-19 L·OVE证据库的研究比例评估全面性,通过计算系统综述实施自身检索时该库已收录的研究比例评估时效性。

主要发现

  • 共识别83篇符合条件的系统综述,纳入2,132项研究。
  • COVID-19 L·OVE证据库的总体全面性为99.67%(2,125/2,132)。
  • 若在COVID-19 L·OVE中而非原始来源中检索,可获得的文章比例为96.48%(2,057/2,132)。
  • 随机试验的全面性与时效性均为100%(82/82)。

临床怎么用

  • 作者认为,使用COVID-19 L·OVE证据库替代传统多数据库手工检索可节省系统综述作者大量工作,并提高证据合成的全面性与及时性;该工具对支持动态证据合成过程尤为重要。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: The coronavirus disease 2019 Living OVerview of Evidence (COVID-19 L·OVE) is a public repository and classification platform for COVID-19 articles. The repository contains more than 430,000 articles as of September 20, 2021 and intends to provide a one-stop shop for COVID-19 evidence. Considering that systematic reviews conduct high-quality searches, this study assesses the comprehensiveness and currency of the repository against the total number of studies in a representative sample of COVID-19 systematic reviews. METHODS: Our sample was generated from all the studies included in the systematic reviews of COVID-19 published during April 2021. We estimated the comprehensiveness of COVID-19 L·OVE repository by determining how many of the individual studies in the sample were included in the COVID-19 L·OVE repository. We estimated the currency as the percentage of studies that was available in the COVID-19 L·OVE repository at the time the systematic reviews conducted their own search. RESULTS: We identified 83 eligible systematic reviews that included 2,132 studies. COVID-19 L·OVE had an overall comprehensiveness of 99.67% (2,125/2,132). The overall currency of the repository, that is, the proportion of articles that would have been obtained if the search of the reviews was conducted in COVID-19 L·OVE instead of searching the original sources, was 96.48% (2,057/2,132). Both the comprehensiveness and the currency were 100% for randomized trials (82/82). CONCLUSION: The COVID-19 L·OVE repository is highly comprehensive and current. Using this repository instead of traditional manual searches in multiple databases can save a great amount of work to people conducting systematic reviews and would improve the comprehensiveness and timeliness of evidence syntheses. This tool is particularly important for supporting living evidence synthesis processes.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Verdugo-Paiva F, Vergara C, Ávila C, et al. COVID-19 Living Overview of Evidence repository is highly comprehensive and can be used as a single source for COVID-19 studies. J Clin Epidemiol. 2022. PMID: 35597369. doi:10.1016/j.jclinepi.2022.05.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。